Citation Impact
Citing Papers
Outcomes of Children With Intermediate-Risk Neuroblastoma After Treatment Stratified by MYCN Status and Tumor Cell Ploidy
2005
The MYCN Enigma: Significance of MYCN Expression in Neuroblastoma
2006
Chromosomal Localization of DNA Amplifications in Neuroblastoma Tumors Using cDNA Microarray Comparative Genomic Hybridization
2003
Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling
2015
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
Expression of the Gene for Multidrug-Resistance–Associated Protein and Outcome in Patients with Neuroblastoma
1996
Proteins regulating Ras and its relatives
1993 StandoutNature
Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas
1992
IDH1andIDH2Mutations in Gliomas
2009 Standout
Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma.
1996
Genetic Staging of Unresectable or Metastatic Neuroblastomain Infants: a Pediatric Oncology Group Study
1997
MYC on the Path to Cancer
2012 Standout
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
1994 Standout
Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.
1991
Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1
1989
The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans
1997 StandoutNatureNobel
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
Oncogenic kinase signalling
2001 StandoutNature
Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice
2011 StandoutNobel
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Ganglioside GM2/GD2 Synthetase mRNA Is a Marker for Detection of Infrequent Neuroblastoma Cells in Bone Marrow
2001
Allelic Loss of Chromosome 1p as a Predictor of Unfavorable Outcome in Patients with Neuroblastoma
1996
Effect of steroid and high-dose immunoglobulin therapy on opsoclonus-myoclonus syndrome occurring in neuroblastoma
1998
Hepatomegaly in neuroblastoma stage 4s: Criteria for treatment of the vulnerable neonate
1996
Cancer Metastasis: Building a Framework
2006 Standout
Germline Mutations of the Paired–Like Homeobox 2B (PHOX2B) Gene in Neuroblastoma
2004
Genetic instabilities in human cancers
1998 StandoutNature
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Targeted Radiotherapy With Submyeloablative Doses of 131I-MIBG Is Effective for Disease Palliation in Highly Refractory Neuroblastoma
2003
Neuroblastoma with a distinct organoid pattern: A clinicopathologic, immunohistochemical, and ultrastructural study
1994
Neuroblastoma: biological insights into a clinical enigma
2003 Standout
A comparative analysis of nuclear DNA content and N-myc gene amplification in neuroblastoma
1990
Notch signaling in neuroblastoma
2004
COMPARATIVE GENOMIC HYBRIDIZATION (CGH) ANALYSIS OF NEUROBLASTOMAS—AN IMPORTANT METHODOLOGICAL APPROACH IN PAEDIATRIC TUMOUR PATHOLOGY
1997
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
1993 Standout
Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid
1999
Successful management of low-stage neuroblastoma without adjuvant therapies: a comparison of two decades, 1972 through 1981 and 1982 through 1992, in a single institution.
1996
Increased incidence of cancer in infants in the U.�S.: 1980-1990
1998
Opsoclonus‐myoclonus‐ataxia syndrome in neuroblastoma: Clinical outcome and antineuronal antibodies—a report from the children's cancer group study
2001
Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy.
1989
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas
1999
Mass screening for neuroblastoma: Quo vadis? A 9-year experience from the pediatric oncology study group of the Kyushu area in Japan
1996
Length of Telomeric Repeats in Neuroblastoma: Correlation with Prognosis and Other Biological Characteristics
1992
Correlating telomerase activity levels with human neuroblastoma outcomes
1995
Prognostic factors in Neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis
1988
Profile of neuroblastoma detected by mass screening, resected after observation without treatment: results of the Wait and See pilot study
2005
Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy.
1996
Clinical and biologic characteristics for recurring neuroblastoma at mass screening cases in Japan
2001
Association of H19 Promoter Methylation with the Expression of H19 and IGF-II Genes in Adrenocortical Tumors
2002
Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma.
1994
Role of Ploidy, Chromosome 1p, and Schwann Cells in the Maturation of Neuroblastoma
1996
Spontaneous regression of localized neuroblastoma detected by mass screening.
1998
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Malignant Gliomas in Adults
2008 Standout
Recent Advances in Neuroblastoma
2010
Apoptosis
2002 Standout
A gene expression atlas of the central nervous system based on bacterial artificial chromosomes
2003 StandoutNature
Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas.
1996
Genetic epidemiology of neuroblastoma: A study of 426 cases at the Institut Gustave‐Roussy in France
2003
Molecular biology and genetics of human neuroblastoma
1989
EMT: 2016
2016 Standout
Asparaginyl Hydroxylation of the Notch Ankyrin Repeat Domain by Factor Inhibiting Hypoxia-inducible Factor
2007 StandoutNobel
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
2002 Standout
Molecular themes in oncogenesis
1991 StandoutNobel
A surgical perspective on the current staging in neuroblastoma— The international neuroblastoma staging system proposal
1989
Comprehensive analysis of chromosome 1p deletions in neuroblastoma
2001
High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma
2000
Origin and physiological roles of inflammation
2008 StandoutNature
Neuroblastoma cells provoke Schwann cell proliferation in vitro
2001
Neuroblastoma
2007 Standout
Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma
1995
Definition of Response And Remission in Children Over one Year of Age with Advanced Neuroblastoma: Proposition for a Scoring System
1987
N-myc oncogene and stage iv-s neuroblastoma preliminary observations on ten cases
1990
Region-specific detection of neuroblastoma loss of heterozygosity at multiple loci simultaneously using a SNP-based tag-array platform
2005
Prognostic Value of Immunocytologic Detection of Bone Marrow Metastases in Neuroblastoma
1991
Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma
1988
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.
1988
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Molecular genetic analysis of familial neuroblastoma
1997
Opsoclonus‐myoclonus‐ataxia syndrome in neuroblastoma: Histopathologic features–A report from the children's cancer group†
2001
Prognostic significance of DNA di-tetraploidy in neuroblastoma
2001
Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and Finland
2000 Standout
Genetic parameters of neuroblastomas
2002
Neurofibromatosis type 1 gene mutations in neuroblastoma
1993
Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma
2005
Natural History and Biology of Stage A Neuroblastoma: A Pediatric Oncology Group Study
2000
Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival.
1990
22q11.2 deletion syndrome
2015 Standout
Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.
1998
In situ detection of DNA fragmentation and expression of bcl-2 in human neuroblastoma: Relation to apoptosis and spontaneous regression
1996
Biology and Genetics of Human Neuroblastomas
1997
Brain Tumors
2001 Standout
Low-grade oligodendroglioma responds to chemotherapy
1996
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
A significant association of Ha-ras p21 in neuroblastoma cells with patient prognosis. A retrospective study of 103 cases
1991
Cancer of the Ovary
2004 Standout
Familial neuroblastoma. Case reports, literature review, and etiologic considerations
1986
Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
1993
Degradation of nuclear oncoproteins by the ubiquitin system in vitro.
1991 StandoutNobel
Dysregulation of Apoptosis in Cancer
1999
Sustained expression of the human protooncogene MYCN rescues rat embryo cells from senescence.
1988 StandoutNobel
The neurocristopathiesA unifying concept of disease arising in neural crest maldevelopment
1974
Mutation and cancer: neuroblastoma and pheochromocytoma.
1972
Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group
2005
Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogene
1987 StandoutScience
Hyperdiploidy Plus Nonamplified MYCN Confers a Favorable Prognosis in Children 12 to 18 Months Old With Disseminated Neuroblastoma: A Pediatric Oncology Group Study
2005
Biologic Factors Determine Prognosis in Infants With Stage IV Neuroblastoma: A Prospective Children’s Cancer Group Study
2000
The International Neuroblastoma Pathology Classification (the Shimada system)
1999
Histopathology and prognosis of Wilms tumorResults from the first national wilms' tumor study
1978 Standout
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burden.
1999
Association of Multiple Copies of the N-mycOncogene with Rapid Progression of Neuroblastomas
1985 Standout
Reconstructing the DNA Methylation Maps of the Neandertal and the Denisovan
2014 StandoutScienceNobel
THE GENETIC DEFECT IN ATAXIA-TELANGIECTASIA
1997
Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13.
2002
Monozygotic siblings discordant for neuroblastoma: Etiologic implications
1985
EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance
2019 StandoutNobel
Organogenesis in a dish: Modeling development and disease using organoid technologies
2014 StandoutScience
Natural Course of Neuroblastoma Detected by Mass Screening: A 5-Year Prospective Study at a Single Institution
2000
Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases
1986 Standout
Terminology and morphologic criteria of neuroblastic tumors
1999
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
1998 StandoutScience
MYCN Expression Is Not Prognostic of Adverse Outcome in Advanced-Stage Neuroblastoma With Nonamplified MYCN
2000
Electrochemiluminescence (ECL)
2004 Standout
High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
2000
Favorable Biology and Outcome of Stage IV-S Neuroblastoma With Supportive Care or Minimal Therapy: A Children’s Cancer Group Study
2000
Malignancy in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome)
2006
Apoptosis, oncosis, and necrosis. An overview of cell death.
1995 Standout
The cancer connection
2002 StandoutNatureNobel
Surfing the p53 network
2000 StandoutNature
Quantitative Tumor Cell Content of Bone Marrow and Blood as a Predictor of Outcome in Stage IV Neuroblastoma: A Children’s Cancer Group Study
2000
Expression of Ha-ras oncogene products in human neuroblastomas and the significant correlation with a patient's prognosis.
1988
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
1998
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
1994 StandoutScience
Molecular Biology of Neuroblastoma
1999
Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study
2000
Ondine's Curse and Neurocristopathy
1980
Favorable Prognosis for Patients 12 to 18 Months of Age With Stage 4 Nonamplified MYCN Neuroblastoma: A Children's Cancer Group Study
2005
myc gene amplification and expression in primary human neuroblastoma.
1990
Surgical Risk Factors in Primary Surgery for Localized Neuroblastoma: The LNESG1 Study of the European International Society of Pediatric Oncology Neuroblastoma Group
2005
N-myc Expression Switched Off and Class I Human Leukocyte Antigen Expression Switched On after Somatic Cell Fusion of Neuroblastoma Cells
1990
Neuroblastoma in the very young child: biological considerations.
1992
The RNA Component of Human Telomerase
1995 StandoutScienceNobel
Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide.
2000
Biologic Variables in the Outcome of Stages I and II Neuroblastoma Treated With Surgery as Primary Therapy: A Children’s Cancer Group Study
2000
The role of the insulin-like growth factors in the central nervous system
1996
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
1998 StandoutScience
MYCN protein expression as a predictor of neuroblastoma prognosis.
1997
Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
1991
P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma
1991
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
2008 Standout
Von Recklinghausen Neurofibromatosis
1981 Standout
Familial predisposition to neuroblastoma does not map to chromosome band 1p36.
1996
SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.
2002
Neurofibromatosis
1977
The natural history of neuroblastic cells in the fetal adrenal gland.
1974
SENSITISATION OF NEUROBLASTOMA PATIENTS AND RELATED AND UNRELATED CONTACTS TO NEUROBLASTOMA EXTRACTS
1976
Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.
1995
Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
1999
Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.
1990
Opsoclonus-Ataxia Caused by Childhood Neuroblastoma: Developmental and Neurologic Sequelae
2002
Works of Jane Chatten being referenced
Epithelial differentiation in Wilms' tumor: a clinicopathologic appraisal.
1976
Neuroblastoma and Digeorge Anomaly
1990
Familial neuroblastoma: A three-generation pedigree and a further association with Hirschsprung disease
1997
Opsoclonus/myoclonus: Paraneoplastic syndrome of neuroblastoma
1996
Prognostic value of histopathology in advanced neuroblastoma: A report from the Childrens Cancer Study Group
1988
Identification of Subsets of Neuroblastomas by Combined Histopathologic and N-myc Analysis
1995
Insulin-like growth factor II-mediated proliferation of human neuroblastoma.
1991
Familial Neuroblastoma
1967
Treatment of children with neurogenic sarcoma experience at the children's hospital of Philadelphia, 1958–1984
1987
A review of 17 IV-S neuroblastoma patients at the children's hospital of Philadelphia
1980
Evaluation of the Shimada classification in advanced neuroblastoma with a special reference to the mitosis-karyorrhexis index: a report from the Childrens Cancer Study Group.
1991
The role of surgery in localized neuroblastoma
1985
Flow cytometric DNA analysis of neuroblastoma. Correlation with histology and clinical outcome
1986
Cerebral Deficits after Burn Encephalopathy
1974
Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of Neuroblastomas
1984
Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
1995
Ovarian Changes in Ataxia Telangiectasia
1967
HLA class I and beta 2-microglobulin expression in frozen and formaldehyde-fixed paraffin sections of neuroblastoma tumors.
1985
Cancer in Neonates: The Experience at The Children's Hospital of Philadelphia
1982
Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin.
1997